Synthesis, anti-inflammatory, cytotoxic, and COX-1/2 inhibitory activities of cyclic imides bearing 3-benzenesulfonamide, oxime, and β-phenylalanine scaffolds: a molecular docking study

References

• (a) Williams DA, Lemke TL, Non-steroidal anti-inflammatory drugs. In Lemke TL, Williams DA, ed. Foye’s principles of medicinal chemistry, 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002:751–93.
   Google Scholar
  (b) Dubost JJ, Soubrier M, Sauvezie B. Le traitement de la polyarthrite rhumatoïde. Évolution des idées et des stratégies. Rev Med Interne 1999;20:171–8.
   PubMed Web of Science ®Google Scholar
  (c) Dannhardt G, Kiefer W, Krämer G, et al. The pyrrole moiety as a template for COX-1/COX-2 inhibitors. Eur J Med Chem 2000;35:499–510.
   PubMed Web of Science ®Google Scholar
  (d) Seibert K, Masferrer JL. Role of inducible cyclooxygenase (COX-2) in inflammation. Receptor 1994;4:17–23.
   PubMedGoogle Scholar
  (e) Fiorucci S, Meli R, Bucci M, Cirino G. Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy? Biochem Pharmacol 2001;62:1433–8.
   PubMed Web of Science ®Google Scholar
• (a) Balaji B, Hariharan S, Shah DB, Ramanathan M. Discovery of potential and selective COX-1 inhibitory leads using pharmacophore modelling, in silico screening and in vitro evaluation. Eur J Med Chem 2014;86:469–80.
   PubMed Web of Science ®Google Scholar
  (b) Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Ann Rev Pharmacol Toxicol 1998;38:97–120.
   PubMed Web of Science ®Google Scholar
  (c) Seibert K, Zhang Y, Leahy K, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci 1994;91:12013–7.
   PubMed Web of Science ®Google Scholar
  (d) Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971;231:232–5.
   PubMedGoogle Scholar
  (e) Kujubu DA, Fletcher BS, Varnum BC, et al. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991;266:12866–72.
   PubMed Web of Science ®Google Scholar
• (a) Crofford LJ. Crofford LJ. COX-1 and COX-2 tissue expression: Implications and predictions. J Rheumatol 1997;24:15–9.
   Web of Science ®Google Scholar
  (b) El-Sayed MA-A, Abdel-Aziz NI, Abdel-Aziz AA-M, et al. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: molecular docking study. Bioorg Med Chem 2011;19:3416–24.
   PubMed Web of Science ®Google Scholar
  (c) Abdel-Sayed MA, Bayomi SM, El-Sherbeny MA, et al. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibition activities and molecular docking study of pyrazoline derivatives. Bioorg Med Chem 2016;24:2032–42.
   PubMed Web of Science ®Google Scholar
  (d) El-Sayed MA-A, Abdel-Aziz NI, Abdel-Aziz AA-M, et al. Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2. Bioorg Med Chem 2012;20:3306–16.
   PubMed Web of Science ®Google Scholar
• (a) Penning TD, Talley JJ, Bertenshaw SR, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib). J Med Chem 1997;40:1347–65.
   PubMed Web of Science ®Google Scholar
  (b) Kurumbail RG, Stevens AM, Gierse JK, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 1996;384:644–8.
   PubMed Web of Science ®Google Scholar
  (c) Michaux C, Charlier C. Structural approach for COX-2 inhibition. Mini Rev Med Chem 2004;4:603–15.
   PubMed Web of Science ®Google Scholar
• (a) Ghosh N, Chaki R, Mandal V, Mandal SC. COX-2 as a target for cancer chemotherapy. Pharmacol Rep 2010;62:233–44.
   PubMed Web of Science ®Google Scholar
  (b) Dai ZJ, Ma XB, Kang HF, et al. Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo. Cancer Cell Int. 2012;12:53.
   PubMed Web of Science ®Google Scholar
• (a) Abdel-Aziz AA-M, Angeli A, El-Azab AS, et al. Synthesis and anti-inflammatory activity of sulfonamides and carboxylates incorporating trimellitimides: dual cyclooxygenase/carbonic anhydrase inhibitory actions. Bioorg Chem 2019;84:260–8.
   PubMed Web of Science ®Google Scholar
  (b) Abdel-Aziz AA-M, El-Azab AS, Abu El-Enin MA, et al. Synthesis of novel isoindoline-1,3-dione-based oximes and benzenesulfonamide hydrazones as selective inhibitors of the tumor-associated carbonic anhydrase IX. Bioorg Chem 2018;80:706–13.
   PubMed Web of Science ®Google Scholar
  (c) Abdel-Aziz AA-M, El-Azab AS, Ekinci D, et al. Investigation of arenesulfonyl-2-imidazolidinones as potent carbonic anhydrase inhibitors. J Enzym Inhib Med Chem 2015;30:81–4.
   PubMed Web of Science ®Google Scholar
  (d) El-Azab AS, Abdel-Aziz AA-M, Ayyad RR, et al. Inhibition of carbonic anhydrase isoforms I, II, IV, VII and XII with carboxylates and sulfonamides incorporating phthalimide/phthalic anhydride scaffolds. Bioorg Med Chem 2016;24:20–5.
   PubMed Web of Science ®Google Scholar
  (e) Abdel-Aziz AA-M, El-Azab AS, Ceruso M, Supuran CT. Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds. Bioorg Med Chem Lett 2014;24:5185–9.
   PubMed Web of Science ®Google Scholar
• (a) El-Azab AS, Abdel-Aziz AA-M, Bua S, et al. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: synthesis, in vitro testing, and in silico assessment. Eur J Med Chem 2019;181:111573.
   PubMed Web of Science ®Google Scholar
  (b) El-Azab AS, Abdel-Aziz AA-M, Bua S, et al. Synthesis and comparative carbonic anhydrase inhibition of new Schiff’s bases incorporating benzenesulfonamide, methanesulfonamide, and methylsulfonylbenzene scaffolds. Bioorg Chem 2019;92:103225.
   PubMed Web of Science ®Google Scholar
  (c) Abdel-Aziz AA-M, El-Azab AS, Bua S, et al. Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivatives. Bioorg Chem 2019;87:425–31.
   PubMed Web of Science ®Google Scholar
• (a) El-Azab AS, Abdel-Aziz AA-M, Bua S, et al. Synthesis of benzensulfonamides linked to quinazoline scaffolds as novel carbonic anhydrase inhibitors. Bioorg Chem 2019;87:78–90.
   PubMed Web of Science ®Google Scholar
  (b) Abdel-Aziz AA-M, El-Azab AS, Ghiaty AH, et al. 4-Substituted benzenesulfonamides featuring cyclic imides moieties exhibit potent and isoform-selective carbonic anhydrase II/IX inhibition. Bioorg Chem 2019;83:198–204.
   PubMed Web of Science ®Google Scholar
• (a) Angeli A, Abdel-Aziz AA-M, Nocentini A, et al. Synthesis and carbonic anhydrase inhibition of polycyclic imides incorporating N-benzenesulfonamide moieties. Bioorg Med Chem 2017;25:5373–9.
   PubMed Web of Science ®Google Scholar
  (b) Mohamed MA, Abdel-Aziz AA-M, Sakr HM, et al. Synthesis and human/bacterial carbonic anhydrase inhibition with a series of sulfonamides incorporating phthalimido moieties. Bioorg Med Chem 2017;25:2524–9.
   PubMed Web of Science ®Google Scholar
  (c) Abdel-Aziz AA-M, Angeli A, El-Azab AS, et al. Synthesis and biological evaluation of cyclic imides incorporating benzenesulfonamide moieties as carbonic anhydrase I, II, IV and IX inhibitors. Bioorg Med Chem 2017;25:1666–71.
   PubMed Web of Science ®Google Scholar
• (a) Abdel-Aziz AA-M, El-Azab AS, Abou-Zeid LA, et al. Synthesis, anti-inflammatory, analgesic and COX-1/2 inhibition activities of anilides based on 5,5-diphenylimidazolidine-2,4-dione scaffold: molecular docking studies. Eur J Med Chem 2016;115:121–31.
   PubMed Web of Science ®Google Scholar
  (b) Al-Suwaidan IA, Alanazi AM, El-Azab AS, et al. Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2. Bioorg Med Chem Lett 2013;23:2601–5.
   PubMed Web of Science ®Google Scholar
• (a) Alanazi AM, El-Azab AS, Al-Suwaidan IA, et al. Structure-based design of phthalimide derivatives as potential cyclooxygenase-2 (COX-2) inhibitors: anti-inflammatory and analgesic activities. Eur J Med Chem 2015;92:115–23.
   PubMed Web of Science ®Google Scholar
  (b) Abdel-Aziz AA-M, El Tahir KEH, Asiri YA. Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: molecular docking study. Eur J Med Chem 2011;46:1648–55.
   PubMed Web of Science ®Google Scholar
• (a) Abdel-Aziz AA-M, El-Azab AS, El-Subbagh HI, et al. Design, synthesis, single-crystal and preliminary antitumor activity of novel arenesulfonylimidazolidin-2-ones. Bioorg Med Chem Lett 2012;22:2008–14.
   PubMed Web of Science ®Google Scholar
  (b) Abdel-Aziz AA-M, El-Azab AS, Alanazi AM, et al. Synthesis and potential antitumor activity of 7-(4-substituted piperazin-1-yl)-4-oxoquinolines based on ciprofloxacin and norfloxacin scaffolds: in silico studies. J Enzym Inhib Med Chem 2016;31:796–809.
   PubMed Web of Science ®Google Scholar
  (c) El-Deeb IM, Bayoumi SM, El-Sherbeny MA, Abdel-Aziz AA-M. Synthesis and antitumor evaluation of novel cyclic arylsulfonylureas: ADME-T and pharmacophore prediction. Eur J Med Chem 2010;45:2516–30.
   PubMed Web of Science ®Google Scholar
  (d) El-Sherbeny MA, Abdel-Aziz AA-M, Ahmed MA. Synthesis and antitumor evaluation of novel diarylsulfonylurea derivatives: molecular modeling applications. Eur J Med Chem 2010;45:689–97.
   PubMed Web of Science ®Google Scholar
• (a) Abdel-Aziz AA-M. Novel and versatile methodology for synthesis of cyclic imides and evaluation of their cytotoxic, DNA binding, apoptotic inducing activities and molecular modeling study. Eur J Med Chem 2007;42:614–26.
   PubMed Web of Science ®Google Scholar
  (b) El-Azab AS, Alanazi AM, Abdel-Aziz NI, et al. Synthesis, molecular modeling study, preliminary antibacterial, and antitumor evaluation of N-substituted naphthalimides and their structural analogues. Med Chem Res 2013;22:2360–75.
   Web of Science ®Google Scholar
• Abdel-Aziz AA-M, El-Azab AS, Attia SM, et al. Synthesis and biological evaluation of some novel cyclic-imides as hypoglycaemic, anti-hyperlipidemic agents. Eur J Med Chem 2011;46:4324–9.
   PubMed Web of Science ®Google Scholar
• Mancilla-Percino T, Trejo-Muñoz CR, Díaz-Gandarilla JA, et al. Isoindoline derivatives of α-amino acids as cyclooxygenase 1 and 2 inhibitors. Arch Pharm Chem Life Sci 2016;349:175–85.
   PubMed Web of Science ®Google Scholar
• Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Exp Biol Med 1962;111:544–7.
   PubMed Web of Science ®Google Scholar
• El-Gamal MI, Bayomi SM, El-Ashry SM, et al. Synthesis and anti-inflammatory activity of novel (substituted)benzylidene acetone oxime ether derivatives: molecular modeling study. Eur J Med Chem 2010;45:1403–14.
   PubMed Web of Science ®Google Scholar
• Adami E, Marazzi-Uberti E, Turba C. Pharmacological research on gefarnate, a new synthetic isoprenoid with an anti-ulcer action. Arch Int Pharmacodyn Ther 1964;147:113–45.
   PubMedGoogle Scholar
• (a) Al-Suwaidan IA, Alanazi AM, Abdel-Aziz AA-M, et al. Design, synthesis and biological evaluation of 2-mercapto-3-phenethylquinazoline bearing anilide fragments as potential antitumor agents: molecular docking study. Bioorg Med Chem Lett 2013;23:3935–41.
   PubMed Web of Science ®Google Scholar
  (b) Mohamed MA, Ayyad RR, Shawer TZ, et al. Synthesis and antitumor evaluation of trimethoxyanilides based on 4(3H)-quinazolinone scaffolds. Eur J Med Chem 2016;112:106–13.
   PubMed Web of Science ®Google Scholar
  (c) Al-Suwaidan IA, Abdel-Aziz AA-M, Shawer TZ, et al. Synthesis, antitumor activity and molecular docking study of some novel 3-benzyl-4(3H)quinazolinone analogues. J Enzym Inhib Med Chem 2016;31:78–89.
   PubMed Web of Science ®Google Scholar
  (d) Alanazi AM, Al-Suwaidan IA, Abdel-Aziz AA-M, et al. Design, synthesis and biological evaluation of some novel substituted 2-mercapto-3-phenethylquinazolines as antitumor agents. Med Chem Res 2013;22:5566–77.
   Web of Science ®Google Scholar
• (a) Uddin MJ, Rao PP, Knaus EE. Design and synthesis of acyclic triaryl (Z)-olefins: a novel class of cyclooxygenase-2 (COX-2) inhibitors. Bioorg Med Chem 2004;12:5929–40.
   PubMed Web of Science ®Google Scholar
  (b) El-Husseiny WM, El-Sayed MA, Abdel-Aziz NI, et al. Structural alterations based on naproxen scaffold: synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking. Eur J Med Chem 2018;158:134–43.
   PubMed Web of Science ®Google Scholar
  (c) El-Azab AS, Abdel-Aziz AA-M, Abou-Zeid LA, et al. Synthesis, antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies. J Enzyme Inhib Med Chem 2018;33:989–98.
   PubMed Web of Science ®Google Scholar
• (a) Goda FE, Abdel-Aziz AA-M, Ghoneim HA. Synthesis and biological evaluation of novel 6-nitro-5-substituted aminoquinolines as local anesthetic and anti-arrhythmic agents: molecular modeling study. Bioorg Med Chem 2005;13:3175–83.
   PubMed Web of Science ®Google Scholar
  (b) Goda FE, Abdel-Aziz AA-M, Attef OA. Synthesis, antimicrobial activity and conformational analysis of novel substituted pyridines: BF3-promoted reaction of hydrazine with 2-alkoxy pyridines. Bioorg Med Chem 2004;12:1845–52.
   PubMed Web of Science ®Google Scholar
  (c) El-Azab AS, Al-Omar MA, Abdel-Aziz AA-M, et al. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study. Eur J Med Chem 2010;45:4188–98.
   PubMed Web of Science ®Google Scholar
• (a) Abdel-Aziz AA-M, Abou-Zeid LA, ElTahir KEH, et al. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones. Eur J Med Chem 2016;121:410–21.
   PubMed Web of Science ®Google Scholar
  (b) Abdel-Aziz AA-M, Abou-Zeid LA, ElTahir KE, et al. Design, synthesis of 2,3-disubstitued 4(3H)-quinazolinone derivatives as anti-inflammatory and analgesic agents: COX-1/2 inhibitory activities and molecular docking studies. Bioorg Med Chem 2016;24:3818–28.
   PubMed Web of Science ®Google Scholar
  (c) Alanazi AM, Abdel-Aziz AA-M, Shawer TZ, et al. Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues: in silico studies. J Enzyme Inhib Med Chem 2016;31:721–35.
   PubMed Web of Science ®Google Scholar
  (d) El-Azab AS, Mary YS, Panicker CY, et al. DFT and experimental (FT-IR and FT-Raman) investigation of vibrational spectroscopy and molecular docking studies of 2-(4-oxo-3-phenethyl-3,4-dihydroquinazolin-2-ylthio)-N-(3,4,5-trimethoxyphenyl) acetamide. J Mol Struct 2016;1113:133–45.
   Web of Science ®Google Scholar
• Molecular Operating Environment (MOE 2008.10) of Chemical Computing Group. Inc. Canada. Available from: http://www.chemcomp.com. [Last accessed 25 Oct 2019].
   Google Scholar
• (a) Sethi KK, Verma SM, Tanç M, et al. Carbonic anhydrase inhibitors: synthesis and inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII with benzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide moiety. Bioorg Med Chem 2013;21:5168–74.
   PubMed Web of Science ®Google Scholar
  (b) Sethi KK, Verma SM, Tanç M, et al. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties. Bioorg Med Chem 2014;22:1586–95.
   PubMed Web of Science ®Google Scholar
  (c) Scozzafava A, Mincione F, Menabuoni L, Supuran CT. Carbonic anhydrase inhibitors: topically acting antiglaucoma sulfonamides incorporating phthaloyl and phthalimido moieties. Drug Des Discov 2001;17:337–48.
   PubMedGoogle Scholar
  (d) Muller GW, U.S., Cyclic amides. 5698579, 16 Dec 1997.
   Google Scholar
  (e) Chowdhury S, Vaishnav R, Panwar N, Haq W. Regioselective β-csp 3-arylation of β-alanine: an approach for the exclusive synthesis of diverse β-aryl-β-amino acids. J Org Chem 2019;84:2512–22.
   PubMed Web of Science ®Google Scholar